Genedis 2018: 3rd World Congress on Genetics, Geriatrics and Neurodegenerative Diseases Research

on .

Download PDF

The 3rd World Congress on Genetics, Geriatrics and Neurodegenerative Diseases Research (GeNeDis 2018) will be held in Toronto Canada, from 25 to 28 of October 2018 (www.genedis.eu).

For the third time three of the most modern and popular scientific areas are brought together in a congress, the 3rd World Congress on Genetics, Geriatrics and Neurodegenerative Disease research with the title: “Health Aging and Mental Wellness in the new digital era”. Leading scientists and researchers from all over the world will discuss the recent developments in the above disciplines, ranging from research progress and the latest scientific discoveries to the clinical and pharmaceutical applications.

GeNeDis 2018 will focus on a strong scientific program combined with teaching, training and live workshops to inform and educate scientist on the latest major challenges in scientific research, the new drug targets, the development of novel biomarkers, the new imaging techniques and the novel protocols for early diagnosis of neurodegenerative diseases, and several other scientific advances. GeNeDis 2018 will feature an internationally recognized widely diverse program, that will contribute in attracting delegates to attend this major event.

The goal of the 3rd World Congress GeNeDis 2018 is to strengthen and broaden the international network by sharing the recent advancements in Genetics, Geriatrics and Neuroscience and by establishing good contacts with all relevant stakeholders – all pursuing the excellence in research, development, education and training with the aim of better and safe health aging.

The conference is organized by the Bioinformatics and Human Electrophysiology Laboratory, (BiHELab), Department of Informatics, Ionian University, Greece, in collaboration with CARGO lab at Wilfrid Laurier University, Ontario, Canada. The Scientific Organizing committee consists of experts from several countries who understand the educational and information business needs of scientists in the research area.

While the European Union aim to strength the research and innovation towards Horizon 2020, the transnational research for genetics, health aging and neurodegeneration will remove any barrier on multi-disciplinary collaboration. Novel approaches include biomarkers, stem cell therapy, protein misfolding, immunotherapy, as well as developments in our understanding of the genetics, the molecular mechanisms and signaling pathways contributing to neuronal dysfunction, nanotechnological products and innovate computational methods will offer new research directions and strategies on future preclinical and clinical studies on neurodegenerative diseases and related disorders, as well as improving of quality services on rehabilitation and health ducation.

Advanced information technologies will be discussed concerning the various research, implementation, and policy, as well as European and global issues in the funding of long term care and medico-social policies regarding elderly people.

The congress aims to inform as well as to promote discussions and networking among scientists and stakeholders from worldwide medical field such as researchers, professors, doctors, nursing staff, hospitals, health and diagnostic centers, harmaceutical companies etc.

The conference proceedings will be published by Springer in the well-known Series: Advances in Experimental Medicine and Biology (AEMB), I.F.: 1.825.